In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Danish biotech firm Genmab has a third member of its executive team. 8 February 2017
Pharmaceutical
French drugmaker Ipsen has added years of big pharma experience to its executive and research and development (R&D) leadership teams. 7 February 2017
Generics
Erez Vigodman is stepping down from his post as chief executive of Teva Pharmaceutical Industries “by mutual agreement,” the Israeli generics giant announced late Monday. 7 February 2017
Biotechnology
France-based Nanobiotix has appointed Alain Dostie as its chief operating officer. 7 February 2017
Pharmaceutical
Thomas Cueni has taken up office as director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on February 1, representing the interests of the research-based biopharmaceutical industry at a global level. 7 February 2017
Pharmaceutical
Sanofi today announces the appointment of Hugo Fry as general manager for the UK and general manager Sanofi Pasteur for the UK & Ireland, and Dr Hubert Bland as UK medical chair and medical head of diabetes and cardiovascular for the UK & Ireland. 1 February 2017
Pharmaceutical
French pharma major Sanofi today announced the appointment of Kathleen Tregoning as a new member of the executive committee, effective February 27, 2017. 30 January 2017
Biotechnology
US biotech firm Juno Therapeutics has appointed Corsee Sanders as executive vice president and head of development operations, effective immediately. 29 January 2017
Generics
On January 26, 2017, Dr Arie Belldegrun resigned as a member of the board of directors of Teva Pharmaceutical Industries, according to a company regulatory filing. 27 January 2017
Pharmaceutical
EMD Serono, the biopharmaceutical business of German pharma major Merck KGaA in the USA and Canada, has announced that Richard Smith has been appointed its head of US fertility and endocrinology. 25 January 2017
Biotechnology
Monoclonal antibody specialist Kymab has appointed Arndt Schottelius as its first executive vice president of research and development (R&D). 23 January 2017
Pharmaceutical
Harout Semerjian has been named Ipsen’s new head of specialty care, international region and global franchises. 20 January 2017
Pharmaceutical
Japanese drugmaker Sosei Group has announced that Andrew Oakley is to become its chief financial officer (CFO). 19 January 2017
Pharmaceutical
A major change at the top of GlaxoSmithKline’s pharmaceutical business has been announced as part of what has been described as ‘succession processes’ at the company. 19 January 2017
Pharmaceutical
Bayer today announced the appointment of Dr Carsten Brunn as president of its pharmaceuticals business in the Americas, comprising the USA, Canada, Central and Latin America. 17 January 2017
Pharmaceutical
UK specialty pharma company Diurnal has announced the appointment of Richard Bungay as chief financial officer (CFO). 12 January 2017
Biotechnology
Friday saw the launch of a new US biotech company, Vir Biotechnology, which is focussed developing cures, treatments and preventions for challenging infectious diseases, with former Biogen chief executive George Scangos heading a team of scientific and industry leaders. 9 January 2017
Biotechnology
3SBio announced today that Zhenping Zhu will join the Chinese biotech firm as president of research & development and chief scientific officer. 9 January 2017
Pharmaceutical
The new man at the helm of Eli Lilly has started off his time as the US pharma major’s chief executive by announcing a series of organizational and leadership structure changes. 6 January 2017
Pharmaceutical
Germany-based MorphoSys has appointed Dr Malte Peters as chief development officer. 6 January 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze